Accurexa's Licensed Patent Application Enters National Phase
SAN FRANCISCO, CA / ACCESSWIRE / March 9, 2015 / Accurexa Inc. (the "Company") (OTCQB:ACXA), a biotechnology company focused on developing and commercializing novel neurological therapies, announced today that the U.S. Patent Application No. PCT/US2013/052301, Microinjection Catheter; UC Case No. SF2012-063, which the Company exclusively licensed from the University of California, San Francisco (UCSF), has entered national phase applications...
Read more









